STOCK TITAN

CONMED Corporation to Participate at the Stifel 2021 Virtual Healthcare Conference on November 16, 2021

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

CONMED Corporation (NYSE: CNMD) has announced that Curt R. Hartman, Chair of the Board, President, and CEO, along with Todd W. Garner, Executive VP and CFO, will present at the Stifel 2021 Virtual Healthcare Conference on November 16, 2021, at 2:40 ET. Interested parties can access a live webcast through the Company’s website. CONMED specializes in providing innovative surgical devices for minimally invasive procedures across various medical specialties, including orthopedics and general surgery.

Positive
  • None.
Negative
  • None.

LARGO, Fla.--(BUSINESS WIRE)--

CONMED Corporation (NYSE: CNMD) today announced that Curt R. Hartman, Chair of the Board, President, and Chief Executive Officer, and Todd W. Garner, Executive Vice President and Chief Financial Officer, will participate in a presentation at the Stifel 2021 Virtual Healthcare Conference at 2:40 ET on Tuesday, November 16, 2021.

A live webcast of the presentation will be accessible through the “Investors” section of the Company’s website at www.conmed.com.

About CONMED Corporation

CONMED is a medical technology company that provides surgical devices and equipment for minimally invasive procedures. The Company’s products are used by surgeons and physicians in a variety of specialties, including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology. For more information, visit www.conmed.com.

Forward-Looking Statements

This press release and the associated presentation may contain forward-looking statements based on certain assumptions and contingencies that involve risks and uncertainties, which could cause actual results, performance, or trends to differ materially from those expressed in the forward-looking statements herein or in previous disclosures. For example, in addition to general industry and economic conditions, factors that could cause actual results to differ materially from those in the forward-looking statements may include, but are not limited to, the risks posed to the Company’s business, financial condition, and results of operations by the COVID-19 global pandemic and the various government and other responses to the pandemic, including deferral of surgeries, reductions in hospital and ambulatory surgery center operating volumes, disruption to potential supply chain reliability, as well as the risk factors discussed in the Company's Annual Report on Form 10-K for the full year ended December 31, 2020 and listed under the heading Forward-Looking Statements in the Company’s most recently filed Form 10-Q. Any and all forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and relate to the Company’s performance on a going-forward basis. The Company believes that all forward-looking statements made by it have a reasonable basis, but there can be no assurance that management’s expectations, beliefs or projections as expressed in the forward-looking statements will actually occur or prove to be correct.

Todd W. Garner

Chief Financial Officer

727-214-2975

ToddGarner@conmed.com

Source: CONMED Corporation

FAQ

What is the presentation date for CONMED at the Stifel 2021 Virtual Healthcare Conference?

CONMED will present at the Stifel 2021 Virtual Healthcare Conference on November 16, 2021.

Who will represent CONMED at the Stifel 2021 Virtual Healthcare Conference?

Curt R. Hartman and Todd W. Garner will represent CONMED at the conference.

What time will CONMED's presentation start at the Stifel Conference?

CONMED's presentation is scheduled to start at 2:40 ET.

Where can I watch the CONMED presentation from the Stifel Conference?

The presentation can be accessed via the 'Investors' section of CONMED's website.

What does CONMED Corporation specialize in?

CONMED specializes in surgical devices and equipment for minimally invasive procedures.

CONMED Corporation

NYSE:CNMD

CNMD Rankings

CNMD Latest News

CNMD Stock Data

2.17B
30.70M
0.58%
114.64%
7.66%
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
United States of America
LARGO